Similar results were also seen in cyclin A2-overexpressing transgenic mice, including the induction of cardiac regeneration, reduced scarring, improved LV function, and prevention of heart failure after myocardial infarction (Cheng et al., 2007). This evidence concerns the gene CCNA2 and heart failure.